Friday, 11 June, 2021 - 12:00
Perth biotech has strong start to trading
A Perron Institute spinout focused on reducing brain damage caused by strokes listed on the ASX this morning, with its share price rising 50 per cent.
![]() |
NEW ROLE: Patryk Kania, Non-Executive Director | 25 Jul 2024 |
![]() |
NEWS: Tagged in Perth biotech has strong start to trading | 11 Jun 2021 |
![]() |
REMUNERATION UPDATE: Ryan Laws, Co-Founder, Non-Executive Director | 03 Nov 2020 |
![]() |
REMUNERATION UPDATE: Ron Weinberger, Chief Executive Officer, Managing Director | 03 Nov 2020 |
![]() |
REMUNERATION UPDATE: Geoff Pocock, Non-Executive Director | 03 Nov 2020 |
![]() |
NEW ROLE: Philip Dubois, Non-Executive Director | 03 Nov 2020 |
![]() |
NEW ROLE: Tony Keane, Non-Executive Director | 03 Nov 2020 |
![]() |
NEW ROLE: John Keep, Non-Executive Chairman, Non-Executive Director | 03 Nov 2020 |
![]() |
NEW ROLE: Scott Kirkland, Co-founder, Chief Executive Officer, Managing Director | 03 Nov 2020 |